A detailed history of Stone X Group Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 50,100 shares of BRTX stock, worth $78,156. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,100
Previous 34,850 43.76%
Holding current value
$78,156
Previous $48,000 112.5%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$1.15 - $2.22 $17,537 - $33,855
15,250 Added 43.76%
50,100 $102,000
Q1 2024

May 01, 2024

BUY
$1.28 - $3.45 $44,608 - $120,232
34,850 New
34,850 $48,000
Q3 2023

Nov 14, 2023

BUY
$1.45 - $4.57 $13,050 - $41,130
9,000 Added 60.48%
23,880 $43,000
Q2 2023

Aug 11, 2023

SELL
$3.49 - $6.49 $258 - $480
-74 Reduced 0.49%
14,880 $66,000
Q4 2021

Feb 10, 2022

BUY
$4.02 - $18.0 $60,115 - $269,172
14,954 New
14,954 $65,000

Others Institutions Holding BRTX

About BioRestorative Therapies, Inc.


  • Ticker BRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,650,030
  • Market Cap $5.69M
  • Description
  • BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...
More about BRTX
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.